|
|
Sight Sciences Inc (NASDAQ: SGHT) |
|
|
|
| |
Sight Sciences Inc 's Leverage Ratio
SGHT's quarterly Leverage Ratio and Total Liabilities, Equity growth
In Spite of the repayements of liabilities of -5.9%, in Q1 2025 ,Leverage Ratio deteriorated to 0.67 reached a new all-time high.
Within Medical Equipment & Supplies industry in the first quarter 2025, 50 other companies have achieved lower Leverage Ratio than Sight Sciences Inc in the Q1 2025. While Leverage Ratio total ranking has deteriorated compared to the fourth quarter 2024 from 692 to 823 .
Explain Leverage Ratio?
How much Total Liabilitiess SGHT´s has?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| SGHT Leverage Ratio |
(Mar 31 2025)
Q1 |
(Dec 31 2024)
Q4 |
(Sep 30 2024)
Q3 |
(Jun 30 2024)
Q2 |
(Mar 31 2024)
Q1 |
| Y / Y Equity Change |
-28.92 % |
-27.19 % |
-25.27 % |
-25.34 % |
-25.39 % |
| Y / Y Total Liabilities Change |
12.3 % |
19.12 % |
-1.88 % |
-2.2 % |
-7.79 % |
| Leverage Ratio MRQ |
0.67 |
0.63 |
0.51 |
0.47 |
0.42 |
| SGHT's Total
Ranking |
# 823 |
# 692 |
# 1030 |
# 944 |
# 867 |
| Seq. Equity Change |
-11.31 % |
-7.83 % |
-6.57 % |
-6.93 % |
-9.16 % |
| Seq. Total Liabilities Change |
-5.9 % |
13.73 % |
1.17 % |
3.72 % |
-0.18 % |
| Leverage Ratio first quarter 2025 Company Ranking |
| Within: |
No. |
| Medical Equipment & Supplies Industry |
# 51 |
| Healthcare Sector |
# 311 |
| Overall Market |
# 823 |
| Leverage Ratio Statistics |
| High |
Average |
Low |
| 0.67 |
0.38 |
0.18 |
| (Mar 31 2025) |
|
(Sep 30 2021) |
Cumulative Sight Sciences Inc 's Leverage Ratio
SGHT's Leverage Ratio for the trailling 12 Months
SGHT Leverage Ratio |
(Mar 31 2025)
12 Months |
(Dec 31 2024)
12 Months |
(Sep 30 2024)
12 Months |
(Jun 30 2024)
12 Months |
(Mar 31 2024)
12 Months |
| Y / Y Equity TTM Growth |
-26.57 % |
-25.76 % |
-25.21 % |
-25.57 % |
-26.6 % |
| Y / Y Total Liabilities TTM Growth |
6.56 % |
1.51 % |
-6.18 % |
-6.98 % |
-6.37 % |
| Leverage Ratio TTM |
0.56 |
0.5 |
0.44 |
0.42 |
0.39 |
| Total Ranking TTM |
# 8
| # 1
| # 3
| # 4
| # 3
|
| Seq. Equity TTM Growth |
-8.03 % |
-7.67 % |
-7.01 % |
-7 % |
-7.02 % |
| Seq. Total Liabilities TTM Growth |
2.87 % |
4.69 % |
-0.49 % |
-0.56 % |
-2 % |
On the trailing twelve months basis Despite of the repayements of liabilities of -5.9% in the trailing twelve months ending in Q1 2025, Leverage Ratio improved to 0.56, a new company high. Leverage Ratio is the average cumulative value over the last four quarters.
Among companies in the Medical Equipment & Supplies industry SGHT recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has deteriorated during the twelve months ending in the Q1 2025, compared to the prior period, from 1 to 8.
Explain Leverage Ratio?
How much Total Liabilitiess SGHT´s has?
| TTM Leverage Ratio Company Ranking |
| Within: |
No. |
| Within the Medical Equipment & Supplies Industry |
# 0 |
| Healthcare Sector |
# 0 |
| Within the Market |
# 8 |
| trailing twelve months Leverage Ratio Statistics |
| High |
Average |
Low |
| 0.56 |
0.39 |
0.21 | | (Mar 31 2025) |
|
(Jun 30 2022) |
| Companies with similar Leverage Ratio in the quarter ending Mar 31 2025, within Medical Equipment & Supplies Industry | Leverage Ratio | Mar 31 2025 MRQ Total Liabilities | Mar 31 2025 MRQ Equity | | Adm Tronics Unlimited Inc | 1.83 | $ 1.229 Millions | $ 0.671 Millions | | Haemonetics Corporation | 1.83 | $ 1,499.343 Millions | $ 820.836 Millions | | Helius Medical Technologies inc | 1.72 | $ 2.204 Millions | $ 1.280 Millions | | Electrocore Inc | 1.72 | $ 7.492 Millions | $ 4.365 Millions | | Artivion Inc | 1.69 | $ 496.911 Millions | $ 294.252 Millions | | Insulet Corporation | 1.64 | $ 2,186.600 Millions | $ 1,330.700 Millions | | Sanara Medtech Inc | 1.60 | $ 58.620 Millions | $ 36.668 Millions | | Vivos Therapeutics Inc | 1.56 | $ 6.875 Millions | $ 4.407 Millions | | Henry Schein Inc | 1.53 | $ 6,058.000 Millions | $ 3,954.000 Millions | | Livanova Plc | 1.47 | $ 1,524.448 Millions | $ 1,034.298 Millions | | Integra Lifesciences Holdings Corp | 1.45 | $ 2,207.455 Millions | $ 1,524.139 Millions | | Masimo Corp | 1.42 | $ 1,346.700 Millions | $ 946.400 Millions | | The Pennant Group Inc | 1.36 | $ 440.026 Millions | $ 323.026 Millions | | Yunhong Green Cti Ltd | 1.35 | $ 14.115 Millions | $ 10.478 Millions | | U S Physical Therapy Inc | 1.28 | $ 640.602 Millions | $ 498.961 Millions | | Conmed Corporation | 1.28 | $ 1,250.095 Millions | $ 977.636 Millions | | Escalon Medical Corp | 1.27 | $ 2.921 Millions | $ 2.295 Millions | | Encision Inc | 1.22 | $ 2.020 Millions | $ 1.651 Millions | | Innovage Holding Corp | 1.19 | $ 291.043 Millions | $ 245.605 Millions | | Vaso Corporation | 1.13 | $ 30.245 Millions | $ 26.650 Millions | | Bausch and Lomb Corp | 1.10 | $ 7,067.000 Millions | $ 6,433.000 Millions | | Cadre Holdings inc | 1.07 | $ 338.731 Millions | $ 317.562 Millions | | Icu Medical Inc | 1.06 | $ 2,103.426 Millions | $ 1,987.689 Millions | | Integer Holdings Corporation | 1.05 | $ 1,682.291 Millions | $ 1,606.704 Millions | | Milestone Scientific Inc | 1.04 | $ 4.626 Millions | $ 4.462 Millions | | Nuwellis Inc | 0.96 | $ 3.428 Millions | $ 3.578 Millions | | Pulmonx Corporation | 0.94 | $ 73.069 Millions | $ 77.667 Millions | | Nexgel Inc | 0.94 | $ 5.228 Millions | $ 5.568 Millions | | Intelligent Bio Solutions Inc | 0.90 | $ 4.471 Millions | $ 4.944 Millions | | Infusystem Holdings Inc | 0.89 | $ 49.134 Millions | $ 55.148 Millions |
|
